621269

Armstrong Pharmaceuticals, Inc. — FEI 3007009553

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 29, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Canton, MA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
440021 CFR 211.186(b)(8)Description of containers, labels, et. al.
673021 CFR 314.80(b)Failure to develop written procedures
682321 CFR 314.80(c)Failure by applicant to report ADE
683021 CFR 314.80(c)(2)Interval
890621 CFR 314.81(b)(1)(i)Mix-up
890821 CFR 314.81(b)(2)(i)Summary
891221 CFR 314.81(b)(2)Timely submission